PubRank

A Pugliese

Author PubWeight™ 66.71‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Dimorphic histopathology of long-standing childhood-onset diabetes. Diabetologia 2010 2.04
2 Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis. Tissue Antigens 2007 1.77
3 Differential regulation of Fas-mediated apoptosis in both thyrocyte and lymphocyte cellular compartments correlates with opposite phenotypic manifestations of autoimmune thyroid disease. Thyroid 2001 1.42
4 The diagnosis of insulitis in human type 1 diabetes. Diabetologia 2013 1.33
5 Insulin VNTR allele-specific effect in type 1 diabetes depends on identity of untransmitted paternal allele. The IMDIAB Group. Nat Genet 1997 1.31
6 Model predictions and evaluation of possible control strategies for the 2009 A/H1N1v influenza pandemic in Italy. Epidemiol Infect 2010 1.29
7 Combined islet and hematopoietic stem cell allotransplantation: a clinical pilot trial to induce chimerism and graft tolerance. Am J Transplant 2008 1.05
8 Differential splicing of the IA-2 mRNA in pancreas and lymphoid organs as a permissive genetic mechanism for autoimmunity against the IA-2 type 1 diabetes autoantigen. Diabetes 2001 1.03
9 Modelling the spatial spread of H7N1 avian influenza virus among poultry farms in Italy. Epidemics 2010 1.01
10 D6S265*15 marks a DRB1*15, DQB1*0602 haplotype associated with attenuated protection from type 1 diabetes mellitus. Diabetologia 2005 1.00
11 Oligella urethralis urosepsis. Clin Infect Dis 1993 0.98
12 The Type I Diabetes Genetics Consortium 'Rapid Response' family-based candidate gene study: strategy, genes selection, and main outcome. Genes Immun 2009 0.98
13 Convergence of a structured metapopulation model to Levins's model. J Math Biol 2004 0.97
14 Alternative splicing of G6PC2, the gene coding for the islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP), results in differential expression in human thymus and spleen compared with pancreas. Diabetologia 2006 0.97
15 Insulin protein and proliferation in ductal cells in the transplanted pancreas of patients with type 1 diabetes and recurrence of autoimmunity. Diabetologia 2008 0.97
16 14th International HLA and Immunogenetics Workshop: report on the HLA component of type 1 diabetes. Tissue Antigens 2007 0.94
17 Variability of the Brachmann-de Lange syndrome. Am J Med Genet 1993 0.90
18 Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type I diabetes. Diabetes 1992 0.89
19 Interaction of human plasma fibronectin with viral proteins of human immunodeficiency virus. FEMS Immunol Med Microbiol 1994 0.89
20 Effects of the human CD38 glycoprotein on the early stages of the HIV-1 replication cycle. FASEB J 1999 0.89
21 On the formulation of epidemic models (an appraisal of Kermack and McKendrick). J Biol Dyn 2012 0.87
22 Circulating levels of IL-18 in adult and paediatric patients with HIV-1 infection. AIDS 2000 0.87
23 Insulin autoimmunity: the rate limiting factor in pre-type I diabetes. J Autoimmun 1992 0.87
24 Induction of interferon by nonreplicating single-stranded RNA virus. Proc Soc Exp Biol Med 1974 0.87
25 A functional CD40 receptor is expressed in pancreatic beta cells. Diabetologia 2005 0.86
26 Scenarios of diffusion and control of an influenza pandemic in Italy. Epidemiol Infect 2008 0.86
27 Legionella micdadei prosthetic valve endocarditis. Infection 1994 0.86
28 Interferon-gamma levels in serum and bronchoalveolar lavage fluid of mice infected with Bordetella pertussis. J Infect Dis 1993 0.84
29 An AIDS model with distributed incubation and variable infectiousness: applications to i.v. drug users in Latium, Italy. Eur J Epidemiol 1992 0.84
30 Modulation of surface transferrin receptors in lymphoid cells de novo infected with human immunodeficiency virus type-1. Cell Biochem Funct 1999 0.83
31 Adhesion of Proteus species to various cell types. Eur J Clin Microbiol 1983 0.83
32 Anti-inflammatory response of IL-4, IL-10 and TGF-beta in patients with systemic inflammatory response syndrome. Mediators Inflamm 2000 0.82
33 Prediction and prevention of type I diabetes. Transplant Proc 1994 0.82
34 Clinical findings associated with Borrelia burgdorferi infection in the dog. Vet Res Commun 2003 0.82
35 Pathogen coexistence induced by density-dependent host mortality. J Theor Biol 1995 0.82
36 Apoptotic DNA fragmentation, and its in vitro prevention by nicotinamide, in lymphocytes from HIV-1-seropositive patients and in HIV-1-infected MT-4 cells. Cell Biochem Funct 1997 0.82
37 Decreased interferon response to polyinosinic-polycytidylic acid in rabbits immunized against the inducer. Proc Soc Exp Biol Med 1972 0.82
38 Limited loss of tolerance to islet autoantigens in ICA+ first degree relatives of patients with type I diabetes expressing the HLA dqb1*0602 allele. J Autoimmun 1996 0.81
39 Advantage of rapamycin over mycophenolate mofetil when used with tacrolimus for simultaneous pancreas kidney transplants: randomized, single-center trial at 10 years. Am J Transplant 2012 0.80
40 [Differences of capacity of human erythrocytes of newborn infants and adults and trypsin-treated erythrocytes to bind rubella virus hemagglutinin]. G Batteriol Virol Immunol 1978 0.80
41 Gametic association of HSP70-1 promoter region alleles and their inclusion in extended HLA haplotypes. Tissue Antigens 1993 0.80
42 The influence of high dose intravenous immunoglobulins on immunological and metabolic pattern in newly diagnosed type I diabetic patients. J Autoimmun 1990 0.80
43 Effect of betamethasone in lungs of mice treated with lymphocytosis-promoting factor of Bordetella pertussis. J Infect Dis 1986 0.80
44 Levels of circulating fibronectin receptor in adult and pediatric patients with human immunodeficiency virus type 1 infection. Clin Diagn Lab Immunol 1994 0.79
45 Type 1 diabetic serum interferes with pancreatic beta-cell Ca2+-handling. Biosci Rep 2007 0.79
46 Growth of Candida albicans in a minimal synthetic medium without biotin. Mycopathologia 1987 0.79
47 Evidence of circulating interferon-gamma in newly diagnosed diabetic children. Acta Paediatr Scand 1984 0.79
48 Establishment of cell cultures from hydatid cysts of Echinococcus granulosus. Int J Parasitol 1988 0.79
49 Cyclic AMP levels in lung and spleen tissue of mice treated with pertussis toxin. Microbiologica 1989 0.79
50 Insulin2 gene (Ins2) transcription by NOD bone marrow-derived cells does not influence autoimmune diabetes development in NOD-Ins2 knockout mice. Scand J Immunol 2009 0.78
51 Analysis of T-lymphocyte subsets after phytohemagglutinin stimulation in normal and type 1 diabetic mothers and their infants. Am J Reprod Immunol 1992 0.78
52 Effects of clenbuterol on haemocoagulation process in calves. J Vet Med A Physiol Pathol Clin Med 2005 0.78
53 Effect of erythromycin on the immune response and interferon production. Immunopharmacology 1988 0.78
54 Effect of HCV infection on THP-1 monocytoid cells. Cell Biochem Funct 2005 0.77
55 Levels of nitric oxide, gamma interferon and interleukin-12 in AIDS patients with toxoplasmic encephalitis. Infection 1999 0.77
56 Inhibition of Fas-mediated apoptosis in mouse insulinoma betaTC-3 cells via an anti-Fas ribozyme. Hum Gene Ther 2000 0.77
57 The HIV/AIDS epidemics among drug injectors: a study of contact structure through a mathematical model. Math Biosci 1997 0.77
58 Effects of long-term zidovudine treatment on cell-mediated immune response and lymphokine production. J Acquir Immune Defic Syndr 1991 0.77
59 Genetics of susceptibility and resistance to insulin-dependent diabetes in stiff-man syndrome. Lancet 1994 0.77
60 HLA similarities indicate shared genetic risk in 21-hydroxylase autoantibody positive South African and United States Addison's disease. Tissue Antigens 2014 0.77
61 Effects of recombinant murine (rm) interleukin-12 and rm interferon-gamma in mice infected with Bordetella pertussis. J Infect Dis 1996 0.77
62 Levels of the bcl-2 protein, fibronectin and alpha(5)beta(1) fibronectin receptor in HIV-1-infected patients with Kaposi's sarcoma. Microbes Infect 2000 0.77
63 Investigation of the potential role of membrane CD38 in protection against cell death induced by HIV-1. J Biol Regul Homeost Agents 1997 0.77
64 Production and release of tumor necrosis factor alfa, interleukin-1B and interleukin-6 by human mononuclear leukocytes stimulated with pertussis toxin. New Microbiol 1993 0.77
65 Human infections tick-transmitted. Panminerva Med 2001 0.77
66 Hydrops foetalis caused by hepatic haemangioma. Acta Paediatr 1998 0.76
67 The role of sex in parasite dynamics: model simulations on transmission of Heligmosomoides polygyrus in populations of yellow-necked mice, Apodemus flavicollis. Int J Parasitol 2006 0.76
68 Enhancement of methotrexate cytotoxicity by modulation of proliferative activity in normal and neoplastic T lymphocytes and in a myeloid leukemia cell line. Tumori 1988 0.76
69 Polygenic control of interferon production induced by poly I:C in vivo. Brief report. Arch Virol 1980 0.76
70 Substrate specificity of the brush border K+-leucine symport of Bombyx mori larval midgut. Insect Biochem Mol Biol 2000 0.76
71 Levels of circulating nitrate/nitrite and gamma interferon not increased in uncomplicated malaria. Infection 1999 0.76
72 Attempted treatment of fulminant viral hepatitis with human fibroblast interferon. Infection 1985 0.76
73 Early administration of an immunomodulator and induction of remission in insulin-dependent diabetes mellitus. J Autoimmun 1990 0.76
74 Expression of the alpha 5 beta 1 fibronectin receptor on T lymphocytes of patients with HIV-1 infection. J Clin Pathol 1996 0.75
75 Regulation of inflammatory responses to Bordetella pertussis by N(G)-monomethyl-L-arginine in mice intranasally infected. Mediators Inflamm 1999 0.75
76 Extrahepatic manifestations of Hepatitis C Virus infection. Dig Liver Dis 2008 0.75
77 Rubella virus hemagglutination with human and animal erythrocytes: effect of age and trypsinization. J Clin Microbiol 1978 0.75
78 Parental gender effects on the insulin-gene-associated susceptibility to insulin-dependent diabetes mellitus. Eur J Clin Invest 1997 0.75
79 Effects of recombinant human interleukin-1 beta on accumulation of inflammatory peritoneal macrophages in mice treated with pertussis toxin. Infect Immun 1990 0.75
80 Effect of distamycin A on interferon production induced in vitro by Newcastle disease virus. Acta Virol 1981 0.75
81 Periodic solutions: a robust numerical method for an S-I-R model of epidemics. J Math Biol 1999 0.75
82 [Hemagglutination inhibition test for rubella virus: control of the removal of complete non-specific inhibitors]. Boll Ist Sieroter Milan 1980 0.75
83 Leucine methyl ester is a powerful allosteric activator of the neutral amino acid cotransport system in Bombyx mori larval midgut. Insect Biochem Mol Biol 2002 0.75
84 Fatal pneumococcal infection: another plea for the pneumococcal vaccine. N Y State J Med 1991 0.75
85 [Effect of tinidazole on T. vaginalis in vitro]. G Batteriol Virol Immunol Microbiol 1972 0.75
86 [Isolation of Salmonella in the Piedmont from 1975 to 1978, with designation of rare strains and evaluation of the frequency of the serotypes]. G Batteriol Virol Immunol 1980 0.75
87 Treatment of alcoholic methadone-maintenance patients with disulfiram. J Stud Alcohol 1975 0.75
88 Effects of Aspergillus sulphureus mycotoxins on Cryptococcus neoformans. Mycoses 1996 0.75
89 Spontaneous release of interferon as a predictor of clinical evolution in HIV-positive subjects. Infection 1991 0.75
90 [Interferon and experimental neoplasms]. G Batteriol Virol Immunol 1976 0.75
91 [Various biological characteristics of Sindbis virus]. G Batteriol Virol Immunol 1985 0.75
92 Comparison of effects of topical levobunolol to a combination of timolol-dorzolamide on intraocular pressure and pulse rate of healthy dogs. Vet Res Commun 2009 0.75
93 The effect of pre-treatment of syngeneic mice with tumour cells cultured in vitro on the induction of a transplantable tumour. G Batteriol Virol Immunol 1977 0.75
94 Use of formalinized human cord blood erythrocytes in the haemagglutination inhibition test for rubella. Acta Virol 1980 0.75
95 In vitro inhibitory activity of citreoviridin against HIV-1 and an HIV-associated opportunist: Candida albicans. J Chemother 1996 0.75
96 Thymostimulin therapy in patients with measles meningoencephalitis. Thymus 1986 0.75
97 Notes on viral oncolysis and on enhancement of tumor cell immunogenicity by adsorption of poorly infectious viruses. G Batteriol Virol Immunol Microbiol 1974 0.75
98 In vitro activity of alpha, beta, gamma human interferons and Aspergillus terreus mycotoxins on cell proliferation. Boll Ist Sieroter Milan 1986 0.75
99 Hemagglutination by natural and synthetic nucleic acids. G Batteriol Virol Immunol 1977 0.75
100 [Leukocyte facilitation in experimental tumors]. G Batteriol Virol Immunol 1977 0.75
101 [Effect of tynidazole on Trichomonas vaginalis in vitro]. G Batteriol Virol Immunol 1973 0.75
102 [Antiviral activity of ARA-A]. G Batteriol Virol Immunol 1982 0.75
103 Yersinia adhesion and in vitro virulence markers. Contrib Microbiol Immunol 1995 0.75
104 [Adhesion of Streptococci to different types of cells]. G Batteriol Virol Immunol 1986 0.75
105 Doppler evaluation of the ophthalmic vasculature in the beagle: normal values. Vet Res Commun 2003 0.75
106 [The immune response to cryotherapy of prostatic carcinoma]. G Batteriol Virol Immunol 1977 0.75
107 [Prenatal infections and concentrations of immunoglobulins in umbilical cord blood: determination of IgM and IgA in 1,202 newborn infants (preliminary note)]. G Batteriol Virol Immunol Microbiol 1974 0.75
108 [Hemagglutinating activity of various viruses on trypsinized erythrocytes]. G Batteriol Virol Immunol 1977 0.75
109 [Cutaneous evaporimetry. III. Cutaneous water loss (CWL) in the suckling infant]. Boll Soc Ital Biol Sper 1979 0.75
110 [Routes of spread of the current rabies epizoonosis in Europe]. G Batteriol Virol Immunol 1979 0.75
111 Modulation of in vitro chemosensitivity in acute myelogenous leukemia cell line by GM-CSF: opposing effects observed with different cytotoxic drugs and time exposure. Leuk Res 1999 0.75
112 [Viral respiratory infections]. Minerva Med 1980 0.75
113 [Action of a synthetic peptide on some syngeneic tumors]. G Batteriol Virol Immunol 1977 0.75
114 Interaction of poly i:c with the cell membrane in trichomonas vaginalis. G Batteriol Virol Immunol 1976 0.75
115 Absence of circulating interferon in acute viral hepatitis. Acta Virol 1984 0.75
116 Effects of pertussis toxin and indomethacin on murine lymphocytes in the bronchoalveolar lavage fluids. FEMS Microbiol Lett 1989 0.75
117 [In vivo and in vitro production of interleukin-1 after febrile convulsions]. Pediatr Med Chir 2001 0.75
118 [Theories concerning the etiology of multiple sclerosis]. G Batteriol Virol Immunol 1978 0.75
119 [Inhibition of pancreatic beta-cell secretion during a "glucose-clamp" in subjects with acanthosis nigricans]. Minerva Med 1989 0.75
120 [In vivo interferon-inducing capacity of a multibacterial extract: prospective new use]. G Batteriol Virol Immunol 1985 0.75
121 Leucine transport in membrane vesicles from Chironomus riparius larvae displays a mélange of crown-group features. Arch Insect Biochem Physiol 2001 0.75
122 [Viral encephalitis transmitted by arthropods]. Minerva Med 1993 0.75
123 [Agnathia, microstomia, synotia]. Pathologica 1990 0.75
124 Meningococcal conjunctivitis. Heart Lung 1992 0.75
125 [Inhibition of rubella virus hemagglutination by dextran sulfates of high molecular weight]. G Batteriol Virol Immunol 1977 0.75
126 [The treatment of bacterial infections of the lower respiratory tract in childhood. An open comparative study of sulbactam/ampicillin vs. ceftazidime]. Clin Ter 1990 0.75
127 Effects of ofloxacin on cell-mediated immune response and lymphokine production. J Antimicrob Chemother 1990 0.75
128 [General considerations on the interferon system]. G Batteriol Virol Immunol 1981 0.75
129 Efficacy of topical antiseptics on staphylococcal colonization of neonates. J Hosp Infect 1992 0.75
130 [Emergent infections]. Minerva Med 1992 0.75
131 [The validity of the certification of natimortality: the experience of a local study]. Epidemiol Prev 1995 0.75
132 [Interaction of poly I-C with membranes of cells stimulated to produce interferon and of cells not so stimulated]. G Batteriol Virol Immunol 1976 0.75
133 Enhancement of tumour growth by pretreatment with tumoral cells adsorbed by poly i:c deae-dextran complex in syngeneic mice. G Batteriol Virol Immunol 1977 0.75
134 Delayed-type hypersensitivity responses in mice treated with pertussis toxin and betamethasone. Boll Ist Sieroter Milan 1988 0.75
135 Effect of thymostimulin on K-562 cells proliferation. Boll Ist Sieroter Milan 1987 0.75
136 [Biological effects of distamycin A]. G Batteriol Virol Immunol 1980 0.75
137 [Effect of long-term treatment with rifampicin, chloramphenicol and cortisone on the production of virus-induced interferon]. G Batteriol Virol Immunol 1984 0.75
138 [Effect of reagents active on specific protein groups on the hemagglutinating activity of Theiler's GD-7 virus]. G Batteriol Virol Immunol 1973 0.75
139 [Immunoglobulin A and M levels in umbilical cord blood]. Ann Ostet Ginecol Med Perinat 1979 0.75
140 Suppression of PHA-induced IFN-gamma production in BALB/c mice. G Batteriol Virol Immunol 1982 0.75
141 Effect of synthetic polynucleotides on the growth of transplantable tumours in BALB/c mice. Experientia 1979 0.75
142 [Recent findings in the field of oncological therapy with interferon]. G Batteriol Virol Immunol 1982 0.75
143 [Assay of IgA specific anti-Trichomonas vaginalis in vaginal secretions by indirect immunofluorescence]. G Batteriol Virol Immunol 1984 0.75
144 Serum reactivity against RINm5F purified membrane antigens (ICMA) in newly diagnosed diabetic subjects. Diabetes Res 1990 0.75
145 Chemotactic activity of pertussis toxin on murine lymphocytes. Its potential role on lymphocyte accumulation in the lung. FEMS Microbiol Immunol 1990 0.75
146 [Larsen's syndrome and severe neurological damage in a newborn]. Pediatria (Napoli) 1982 0.75
147 Defective interferon-alpha production in children with recurrent respiratory tract infections. A primary or secondary deficiency? Boll Ist Sieroter Milan 1985 0.75
148 [Aspecific inhibitors of rubella virus hemagglutination in normal and thyroidectomized rats]. G Batteriol Virol Immunol 1977 0.75
149 [Inhibition of pancreatic beta-cell secretion during "glucose clamp" in patients with polycystic ovary syndrome]. Minerva Endocrinol 1989 0.75
150 Polarization and capping of lymphocytes in HIV infection. Microbiologica 1990 0.75
151 [Effects of a synthetic peptide on the cytotoxic activity of the lymphocytes of animals with tumors]. G Batteriol Virol Immunol 1977 0.75
152 [Effect of the cell dose on the development of 2 transplantable tumors in a syngeneic host]. G Batteriol Virol Immunol 1977 0.75
153 Limits of a multi-patch SIS epidemic model. J Math Biol 2002 0.75
154 Interferon production on mouse fibroblasts induced by various viruses. Boll Ist Sieroter Milan 1980 0.75